Marvin, asthenis and SafetyEasy® join forces under AB Cube Group
Integrated portfolio of real-world and clinical trial data strengthens oncology research and safety workflows.
(PresseBox) - AB Cube Group is bringing together Marvin, asthenis, and SafetyEasy® into one integrated portfolio of solutions for real-world and clinical trial data — supporting oncology research, clinical studies, and pharmacovigilance workflows across Europe.
As part of this transformation, EvidentIQ Germany GmbH is now operating under the name AB Cube Germany GmbH. In addition, asthenis Medical GmbH has been integrated into AB Cube Germany GmbH.
This combination strengthens AB Cube’s footprint in Germany and Europe and expands its offering for life-science organizations — covering clinical data management, structured oncology documentation, tumor boards, and regulatory safety processes.
Integrated solutions for oncology research and safety
The transformation unites three complementary strengths:
Marvin — clinical data management for clinical trials and registries, with a strong focus on oncology workflows
asthenis — tumor documentation, oncology registries, and multidisciplinary tumor boards
SafetyEasy® — pharmacovigilance, vigilance, and regulatory safety workflows
The integration links Marvin’s oncology trial expertise with asthenis’ strengths in tumor documentation and tumor boards, that connects clinical trial data with structured real-world oncology care data.
SafetyEasy® complements the portfolio by adding safety and vigilance workflows, enabling a more integrated approach across clinical trials, real-world data, and regulatory compliance.
Together, AB Cube Group now supports customers with an integrated set of tools for:
Clinical data management for studies and registries
Oncology documentation and structured real-world data capture
Tumor conferences and tumor boards
Pharmacovigilance and vigilance reporting
Regulatory compliance workflows
For further information on AB Cube Group, please contact AB Cube Germany GmbH.
About AB Cube SAS AB Cube SAS is a pioneer in cloud-based vigilance and safety software for the life sciences industry. Since 2006, AB Cube has developed innovative SaaS solutions, including the SafetyEasy® Suite, that help organizations worldwide manage complex safety, pharmacovigilance, medical device vigilance, cosmetic vigilance, and regulatory reporting workflows with flexibility, automation, and compliance at their core.
AB Cube Germany GmbH, (formerly XClinical), is a leading European provider of eClinical technologies and the developer of the platforms Marvin EDC and asthenis.
Marvin offers an integrated suite of clinical modules, including EDC, IWRS/RTSM, Medical Coding, ePRO, and advanced reporting tools, designed to support complex and oncology-focused clinical trials.
asthenis is an oncology-focused documentation, registry, and tumour board solution used primarily by hospitals and academic institutions. It captures real-world cancer patient data from routine clinical practice and supports registries and outcomes research.
Unternehmensinformation / Kurzprofil:
AB Cube Germany GmbH, (formerly XClinical), is a leading European provider of eClinical technologies and the developer of the platforms Marvin EDC and asthenis.
Marvin offers an integrated suite of clinical modules, including EDC, IWRS/RTSM, Medical Coding, ePRO, and advanced reporting tools, designed to support complex and oncology-focused clinical trials.
asthenis is an oncology-focused documentation, registry, and tumour board solution used primarily by hospitals and academic institutions. It captures real-world cancer patient data from routine clinical practice and supports registries and outcomes research.
Datum: 12.02.2026 - 12:00 Uhr
Sprache: Deutsch
News-ID 732661
Anzahl Zeichen: 3545
contact information:
Contact person: Jens Wissing
Town:
München
Kategorie:
Manufacturing & Production
Diese Pressemitteilung wurde bisher 307 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Marvin, asthenis and SafetyEasy® join forces under AB Cube Group"
steht unter der journalistisch-redaktionellen Verantwortung von
AB Cube Germany GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
